Protagonist Therapeutics Inc. (PTGX)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary 
XMEX $
128. 75
-7.8
-5.7122%
$
9.24B Market Cap
- P/E Ratio
- Div Yield
886,812 Volume
0.75 Eps
$ 136.55
Previous Close 
Want to track PTGX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Protagonist Therapeutics Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| RL Richard Law Goldman Sachs | 1,445.61 | $216,841.38 | $186,208.92 | -$30,632.46 | -14.13% |
2026 © Marketlog. All Rights Reserved.
